Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 943-428-1 | CAS number: -
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Basic data given (analytical purity of test substance not specified).
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 966
- Report date:
- 1966
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- yes
- Remarks:
- (analytical purity of test substance not specified)
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Tween 61
- IUPAC Name:
- Tween 61
- Details on test material:
- - Name of test material (as cited in study report): Tween 61
- Physical state: tan solid
- Lot/batch No.: 211
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Manor Farms Research, Inc.
- Weight at study initiation: 150 g (141-157 g)
- Fasting period before study: 16 h
- Diet: ad libitum after dosing
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Remarks:
- , but melted to approximately 40°C
- Doses:
- 35500 and 39800 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: at intervals during the first six hours after dosing and daily thereafter up to the 14th day
- Necropsy of survivors performed: yes (adrenals, bladder, liver, spleen, stomach, kidneys, lungs, thymus, heart, small and large intestine)
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 39 800 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No deaths were observed.
- Clinical signs:
- other: Most of the animals had diarrhea: 39800 mg/kg: 2/10 at 19 hours, 4/10 at 21 hours, 9/10 (2/10 slight degree) at 24 hours, 4/10 at 48 hours 35500 mg/kg: 10/10 within 22 hours through 24 hours, 3/10 slight degree at 48 hours
- Gross pathology:
- The following effects were observed:
39800 mg/kg:
bladder: 3/10 distended with urine
heart: 2/10 soft
kidneys: 4/10 (2/4 slight) hydronephrosis
lungs: 3/10 focal hemorrhage, 2/10 slightly congested
35500 mg/kg:
bladder: 2/10 (1/2 slight) distended with urine
heart: 5/10 (1/5 slight) soft
kidneys: 5/10 (1/5 slight) hydronephrosis
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- CLP: not classified
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
